| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CFO &Chief Strategy Officer
1 company
Liang Howard is a CFO &Chief Strategy Officer at BeOne Medicines Ltd.. Recent SEC Form 4 filings include 0 buys and 44 sells.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28, 2021 | ONC Beone Medicines Ltd. | CFO &Chief Strategy Officer | Sell | 446 | $365.00 | $162,790.00 | -100% | +5.4% | -53.9% | |
| Jun 18, 2021 | ONC Beone Medicines Ltd. | CFO &Chief Strategy Officer | Sell | 486 | $325.89 | $158,383.46 | -100% | +19.7% | -58.9% | |
| Jun 7, 2021 | ONC Beone Medicines Ltd. | CFO &Chief Strategy Officer | Sell | 650 | $354.16 | $230,202.50 | -100% | +0.7% | -55.1% | |
| Jan 15, 2021 | ONC Beone Medicines Ltd. | CFO &Chief Strategy Officer | Sale+OE | 14,000 | $344.85 | $4,827,945.23 | -70.3% | - | - | |
| Dec 14, 2020 | ONC Beone Medicines Ltd. | CFO &Chief Strategy Officer | Sale+OE | 91,900 | $229.04 | $21,048,454.15 | -16.4% | - | - | |
| Oct 5, 2020 | ONC Beone Medicines Ltd. | CFO &Chief Strategy Officer | Sale+OE | 14,000 | $299.60 | $4,194,413.48 | -15.1% | - | - | |
| Sep 14, 2020 | ONC Beone Medicines Ltd. | CFO &Chief Strategy Officer | Sale+OE | 14,000 | $250.27 | $3,503,763.52 | -29.6% | - | - | |
| Jun 29, 2020 | ONC Beone Medicines Ltd. | CFO &Chief Strategy Officer | Sell | 300 | $191.23 | $57,368.01 | -100% | - | - | |
| Jun 8, 2020 | ONC Beone Medicines Ltd. | CFO &Chief Strategy Officer | Sell | 453 | $170.84 | $77,390.52 | -100% | - | - | |
| Nov 18, 2019 | ONC Beone Medicines Ltd. | CFO &Chief Strategy Officer | Sale+OE | 25,000 | $194.34 | $4,858,616.04 | -26.8% | - | - |